Search
Dichlorophen
go.drugbank.com/drugs/DB11396InvestigationalVet approvedDichlorophen is an antimicrobial agent shown to exert activity against cestodes, protozoa, fungi, and bacteria.
Exbivirumab
go.drugbank.com/drugs/DB17747ExperimentalExbivirumab is an investigational monoclonal antibody. … It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies to the hepatitis B virus (HBV) surface antigen.[A259202]
Synonyms: HBV-Ab 19AMP-101
go.drugbank.com/drugs/DB18253ExperimentalAMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
ICX-RHY
go.drugbank.com/drugs/DB05716ExperimentalICX-RHY is an investigational therapy comprised of cultured allogeneic fibroblasts.
16-Bromoepiandrosterone
go.drugbank.com/drugs/DB05107Investigational16-Bromoepiandrosterone is an injectable formulation of a compound called alpha-epi-bromide. … It is a chemical relative of DHEA which was selected for development after it showed antiretroviral activity in laboratory tests.
Alinidine
go.drugbank.com/drugs/DB20618ExperimentalAlinidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Alinidine is a a2 adrenoreceptor agonist. Alinidine has a monoisotopic molecular weight of 269.05 Da.
Synonyms: St 567 br (as hbr)Goxalapladib
go.drugbank.com/drugs/DB20736ExperimentalGoxalapladib is a small molecule drug. The usage of the INN stem '-pladib' in the name indicates that Goxalapladib is a phospholipase A2 inhibitor. … Goxalapladib has a monoisotopic molecular weight of 718.29 Da.
Indanidine
go.drugbank.com/drugs/DB20950ExperimentalIndanidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Indanidine is a a2 adrenoreceptor agonist. … Indanidine has a monoisotopic molecular weight of 215.12 Da.
NXN-188
go.drugbank.com/drugs/DB06096InvestigationalNXN-188 is a first-in-class, dual-action small molecule incorporating both neuronal nitric oxide synthase (nNOS) inhibition and 5-HT agonism that is being developed for the treatment of acute migraine.